Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Other Announcement

Kobo Biotech Other Announcement

Kobo Biotech filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter Arch Pharmalabs holds 44.95% of the company.

Source

BSE filing, NSE: AVONLIFE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Kobo Biotech Ltd: key numbers

Share price
₹3.80
Market cap
₹9.05 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-4.93 Cr
P/E (TTM)
-1.8×Sector 45.9×
Promoter holding
44.95%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Kobo Biotech Ltd

All →

Other other announcement announcements

All →